B6.MIP-TF mice harbor the tri-fusion transgene of three imaging reporters, luciferase/EGFP/thymidine kinase, under the control of mouse insulin promoter. Longitudinal noninvasive imaging of beta cells in the same transgenic animal by CCD and microPET, and the identification of beta cells at the cellular level by fluorescent microscopy is possible. This transgenic model provides a new tool for monitoring beta cells from the single cell level to non-invasive longitudinal assessments of beta cells in animal models of type 1 diabetes and type 2 diabetes.
Dr. Daniel L Kaufman, UCLA School of Medicine
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Reporter) |
C57BL/6J mice carrying tri-fusion transgene Ins2-luc/EGFP/Tk, commonly called MIP-TF, line 300 express a luciferase/enhanced green fluorescent protein/thymidine kinase fusion protein (luc/EGFP/Tk) under the control of mouse insulin promoter (Ins2) and are viable, fertile and exhibit no gross physical or behavioral abnormalities. Transgene expression, determined by luciferase enzymatic activity and green fluorescence is exclusive to the pancreas, specifically the insulin producing cells. Transgene expression appears to have no effect on weight, islet morphology, fasting blood glucose, or response to glucose challenge when compared to wild-type controls. This trifusion reporter model should enable longitudinal noninvasive imaging of beta cells in the same animal by cooled charge coupled device (CCD) and micro positron emission tomography (microPET), and identification of beta cells at the cellular level by fluorescent microscopy. There is a correlation between CCD and microPET signals from the pancreas region of the individual transgenic mice. After low dose streptozotocin treatment to induce type 1 diabetes, there is a reduction in the bioluminescence signals from the pancreas prior to the appearance of hyperglycemia. Conversely, pancreatic bioluminescence signals from the pancreas progressively increase (3.6 fold higher compared to control mice) in mice fed a high fat diet to model early type 2 diabetes. This transgenic model provides a new tool for monitoring beta cells from the single cell level to non-invasive longitudinal assessments of beta cells in animal models of type 1 diabetes and type 2 diabetes.
The transgene consists of a mouse insulin promoter, (MIP, Ins2) driving a trifusion imagining reporter consisting of a bioluminescent reporter from a modified firefly luciferase gene (luc) fused to a fluorescent reporter, enhanced green fluorescent protein (EGFP) derived from the jellyfish Aequorea Victoria, which is fused to a positron emission tomography reporter, herpes simplex virus 1 sr39 thymidine kinase (HSV-1 sr39-TK).
This Ins2-luc/EGFP/Tk transgene (commonly referred to as MIP-TF) was microinjected into C57BL/6 embryos. Several founders were identified and evaluated. The donating investigator reported that founder line 300 has been maintained on a C57BL/6 background (see SNP note below). In 2010, The T1DR received this transgenic strain and mated to C57BL/6J for 1 generation prior to sibling mating.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, all 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a C57BL/6N genetic background.
Expressed Gene | GFP, Green Fluorescent Protein, |
---|---|
Expressed Gene | luc, luciferase, firefly |
Expressed Gene | HSV-TK, herpes simplex virus thymidine kinase, |
Site of Expression | A luciferase/enhanced green florescent protein/thymidine kinase fusion protein (luc/EGFP/Tk) is expressed in insulin producing beta cells of the pancreas. |
Allele Name | transgene insertion 300, Daniel Kaufman |
---|---|
Allele Type | Transgenic (Reporter) |
Allele Synonym(s) | MIP-TF |
Gene Symbol and Name | Tg(Ins2-luc/EGFP/TK)300Kauf, transgene insertion 300, Daniel Kaufman |
Gene Synonym(s) | |
Promoter | Ins2, insulin II, mouse, laboratory |
Expressed Gene | GFP, Green Fluorescent Protein, |
Expressed Gene | luc, luciferase, firefly |
Expressed Gene | HSV-TK, herpes simplex virus thymidine kinase, |
Site of Expression | A luciferase/enhanced green florescent protein/thymidine kinase fusion protein (luc/EGFP/Tk) is expressed in insulin producing beta cells of the pancreas. |
Strain of Origin | C57BL/6 |
Chromosome | UN |
Molecular Note | The transgene consists of a mouse insulin promoter, (MIP, Ins2) driving a trifusion imagining reporter consisting of a bioluminescent reporter from a modified firefly luciferase gene (luc) fused to a florescent reporter, enhanced green florescent protein (EGFP) derived from the jellyfish Aequorea Victoria, which is fused to a positron emission tomography reporter, herpes simplex virus 1 sr39 thymidine kinase (HSV-1 sr39-TK). |
Mutations Made By | Dr. Daniel Kaufman, UCLA School of Medicine |
When maintaining a live colony, these mice can be bred non-carrier x hemizygous and reciprocal.
When using the B6.MIP-TF mouse strain in a publication, please cite the originating article(s) and include JAX stock #012943 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(Ins2-luc/EGFP/TK)300Kauf |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.